Studies have now also proposed CD133, CXCR4, and cMet as PaCSCs specific cell markers and demonstrated that cMet positive cells from human pancreatic cancer have increased tumor potential and self-renewal ability [25,28,33,34,35,36]. This evidence concerns the gene MET and neoplasm.